The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension

European Respiratory Journal

Volumn 26, Issue 1, 2005, Pages 168-173

  Elliot, C A ^a   Stewart, P ^a   Webster, V J ^a   Mills, G H ^a   Hutchinson, S P ^a   Howarth, E S ^b   Bu'Lock, F A ^c   Lawson, R A ^a   Armstrong, I J ^a   Kiely, David G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Caesarean section; Iloprost; Local anaesthesia; Pregnancy; Pulmonary hypertension

Indexed keywords

BOSENTAN; HEPARIN; ILOPROST; LOW MOLECULAR WEIGHT HEPARIN; UNIPROST; WARFARIN;

ARTICLE; CASE REPORT; CESAREAN SECTION; CONGENITAL MALFORMATION; DRUG INDUCED HEADACHE; DRUG USE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; HIGH RISK PREGNANCY; HOSPITAL ADMISSION; HUMAN; INFANT MORTALITY; INJECTION SITE; LOCAL ANESTHESIA; MATERNAL MORTALITY; MEDICAL NEBULIZER; OUTCOMES RESEARCH; PAIN; PREGNANCY DISORDER; PRIORITY JOURNAL; PUERPERIUM; PULMONARY HYPERTENSION; RECURRENT INFECTION; TERATOGENICITY;

ADMINISTRATION, INHALATION; ADULT; CESAREAN SECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 21744442457     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00128504     Document Type: Article

References (11)

1. Rich S, Dantzker DR, Ayres SM, et al. Primary Pulmonary Hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-223.
2. Rubin LJ, Mendoza J, Hood M, et al. Treatment of pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomised trial. Ann Intern Med 1990; 112: 485-491.
3. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: A systematic overview from 1978 through 1996. J Am Coll Cardiol 1998; 31: 1650-1657.
4. Weiss BM, Maggiorini M, Jenni R, et al. Pregnant patient with primary pulmonary hypertension: Inhaled pulmonary vasodilators and epidural anaethesia for caesarean delivery. Anaesthesiology 2000; 92: 1191-1194.
5. Easterling TR, Ralph DD, Scmucker BC. Pulmonary hypertension in pregnancy: Treatment with pulmonary vasodilators. Obstet Gynaecol 1999; 93: 494-498.
6. Stewart R, Tuazon D, Olson G, Duarte AG. Pregnancy and primary pulmonary hypertension. Successful outcome with epoprostenol therapy. Chest 2001; 119: 973-975.
7. Hill LL, De Wet CJ, Jacobsohn E, Leighton BL, Tymkew H. Peripartum substitution of inhaled for intravenous prostacyclin in a patient with primary pulmonary hypertension. Anaesthesiology 2004; 100: 1603-1605.
8. Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Br J Anaesth 2001; 87: 295-298.
9. rd TRAX PMS Data Report to CPMP for the period from 24 May 2002 to 19 February 2003 (Actelion Pharmaceuticals, data on file).
10. Hunter S, Robson SC. Adaption of the maternal heart in pregnancy. Br Heart J 1992; 68: 540-543.
11. Olschewski H, Simonneau G, Galie N, et al. Aerosolized Iloprost Randomized Study Group. Inhaled Iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-329.